StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Excerpts from the Final Prospectus dated Nov 26th

<< Previous

Bullboard Posts

Next >>

Comment by Bully88on Dec 02, 2020 11:34am

120 Views

Post# 32018047

RE:RE:RE:RE:RE:RE:RE:Excerpts from the Final Prospectus dated Nov 26th

yes and all these new clients and contracts came after q3 ended. Covid numbers are spiking everywhere.

of course we are speculating.

thats what trading stocks is all about.

risk losing maybe 50% loss before you pull out vs rewards of 1000s %

JMO

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec